Bionik Laboratories Corp. Disclosure


Bionik Laboratories Corp. (OTC: BNKL) is a client of PCG Advisory, Inc. Bionik Laboratories Corp. has an agreement in place to pay PCG a monthly cash fee of $8,000 and a one-time stock fee of 20,000 common shares restricted under Rule 144, with additional payments of 10,000 common shares restricted under Rule 144, for months 4, 5, and 6, for PCG investor awareness and investor relations advisory services.

Investor awareness and investor relations services and programs are designed to help small-cap companies communicate their investment characteristics. PCG investor awareness and advisory services include multimedia marketing and other awareness services.